PFA Pension Forsikringsaktieselskab Makes New $50.01 Million Investment in Zoetis Inc. $ZTS

Key Points

• PFA Pension acquired a new stake of 395,623 Zoetis shares valued at approximately $50.01 million, leaving the firm with about 0.09% ownership as institutional investors hold roughly 92.8% of the stock.
• Analyst coverage is mixed: several firms cut targets or ratings recently but Citigroup initiated a Buy at $145, while the MarketBeat consensus remains a Hold with a $151.75 price target.
• Zoetis beat quarterly estimates (EPS $1.48 vs. $1.40; revenue $2.39B) and set FY2026 guidance of 7.00–7.10 EPS, and declared a quarterly dividend of $0.53 (annualized yield ~1.9%).

PFA Pension Forsikringsaktieselskab acquired a new position in Zoetis Inc. (NYSE:ZTS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 395,623 shares of the company's stock, valued at approximately $50,011,000. PFA Pension Forsikringsaktieselskab owned 0.09% of Zoetis at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of ZTS. Global Wealth Strategies & Associates purchased a new stake in Zoetis in the fourth quarter worth about $25,000. Lodestone Wealth Management LLC purchased a new stake in Zoetis in the fourth quarter worth about $30,000. KERR FINANCIAL PLANNING Corp purchased a new stake in Zoetis in the third quarter worth about $31,000. Holos Integrated Wealth LLC purchased a new stake in Zoetis in the fourth quarter worth about $32,000. Finally, Board of the Pension Protection Fund purchased a new stake in Zoetis in the fourth quarter worth about $38,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ZTS has been the subject of several research analyst reports. Weiss Ratings lowered shares of Zoetis from a "hold (c-)" rating to a "sell (d+)" rating in a report on Friday, March 27th. Citigroup assumed coverage on shares of Zoetis in a report on Wednesday, April 15th. They set a "buy" rating and a $145.00 target price for the company. Piper Sandler reiterated a "neutral" rating and set a $135.00 target price (down from $190.00) on shares of Zoetis in a report on Thursday, January 22nd. UBS Group lowered their target price on shares of Zoetis from $136.00 to $130.00 and set a "neutral" rating for the company in a report on Tuesday, April 28th. Finally, Leerink Partners reiterated a "market perform" rating on shares of Zoetis in a report on Tuesday, March 10th. Seven investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $151.75.

Zoetis Price Performance

Shares of ZTS opened at $114.22 on Friday. The company has a market capitalization of $48.05 billion, a P/E ratio of 18.97, a price-to-earnings-growth ratio of 1.76 and a beta of 0.87. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71. The firm has a 50 day moving average of $119.93 and a 200 day moving average of $124.67. Zoetis Inc. has a twelve month low of $112.97 and a twelve month high of $172.23.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.36 billion. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The firm's quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, equities research analysts anticipate that Zoetis Inc. will post 7.01 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be given a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a dividend yield of 1.9%. Zoetis's dividend payout ratio (DPR) is 35.22%.

About Zoetis

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.